Savarino Andrea, Boelaert Johan R, Cassone Antonio, Majori Giancarlo, Cauda Roberto
Department of Infectious Diseases, Università Cattolica del Sacro Cuore, Rome, Italy.
Lancet Infect Dis. 2003 Nov;3(11):722-7. doi: 10.1016/s1473-3099(03)00806-5.
Chloroquine is a 9-aminoquinoline known since 1934. Apart from its well-known antimalarial effects, the drug has interesting biochemical properties that might be applied against some viral infections. Chloroquine exerts direct antiviral effects, inhibiting pH-dependent steps of the replication of several viruses including members of the flaviviruses, retroviruses, and coronaviruses. Its best-studied effects are those against HIV replication, which are being tested in clinical trials. Moreover, chloroquine has immunomodulatory effects, suppressing the production/release of tumour necrosis factor alpha and interleukin 6, which mediate the inflammatory complications of several viral diseases. We review the available information on the effects of chloroquine on viral infections, raising the question of whether this old drug may experience a revival in the clinical management of viral diseases such as AIDS and severe acute respiratory syndrome, which afflict mankind in the era of globalisation.
氯喹是一种自1934年起就为人所知的9-氨基喹啉。除了其广为人知的抗疟作用外,该药物还具有一些有趣的生化特性,可能适用于某些病毒感染。氯喹具有直接抗病毒作用,可抑制包括黄病毒、逆转录病毒和冠状病毒成员在内的多种病毒复制中依赖pH的步骤。其研究得最为透彻的作用是针对HIV复制的作用,目前正在临床试验中进行测试。此外,氯喹具有免疫调节作用,可抑制肿瘤坏死因子α和白细胞介素6的产生/释放,而这两种物质介导了几种病毒性疾病的炎症并发症。我们综述了关于氯喹对病毒感染作用的现有信息,提出了这样一个问题:在全球化时代困扰人类的艾滋病和严重急性呼吸综合征等病毒性疾病的临床治疗中,这种老药是否会迎来复兴。